C-fos Gene and Protein Expression in Pelvic Endometriosis: a Local Marker of Estrogen Action

Overview

Journal J Mol Histol

Specialty Biochemistry

Date 2009 Feb 10

PMID 19199093

Citations 12

Authors

Debora M Morsch

Marcia M Carneiro

Sheila B Lecke

Fabiano C Araujo

Aroldo F Camargos

Fernando M Reis

Poli Mara Spritzer

Affiliations

Soon will be listed here.

Abstract

Endometriosis is an estrogen-dependent disease, causing pelvic pain and infertility. c-fos is an early transcription factor that has been reported to be related to estradiol-dependent cell proliferation. The aim of the present study was to assess the c-fos gene and protein expression in pelvic endometriotic implants in comparison to normal endometrium from infertile women. An open, prospective and controlled study included 15 infertile women with endometriosis and 19 control infertile women. Endometrial and endometriotic biopsies were performed at the follicular phase and the samples were processed for RT-PCR and immunohistochemistry. ERalpha mRNA levels were similar in the endometriotic implants/eutopic endometrium from women with endometriosis and in normal tissue (P = 0.649). The aromatase gene, however, was not expressed in the eutopic endometrium from either control or endometriosis groups, and was only expressed in 50% of endometriotic implants (P = 0.044). c-fos gene expression was higher in endometriotic implants (1.32 +/- 0.13; P = 0.011) than in eutopic endometrium from patients with endometriosis (0.97 +/- 0.11) or from the control group (0.91 +/- 0.05). In addition, immunohistochemistry showed a more abundant distribution of c-Fos in the stroma of endometriotic tissue compared to eutopic endometrium. These data suggest that c-fos may play a role in the molecular mechanisms of estrogen action on the induction, promotion or progression of endometriosis.

Citing Articles

Mining phase separation-related diagnostic biomarkers for endometriosis through WGCNA and multiple machine learning techniques: a retrospective and nomogram study.

Liang Q, Yang S, Mai M, Chen X, Zhu X J Assist Reprod Genet. 2024; 41(5):1433-1447.

PMID: 38456992 PMC: 11143086. DOI: 10.1007/s10815-024-03079-9.

Machine learning-based integrated identification of predictive combined diagnostic biomarkers for endometriosis.

Zhang H, Zhang H, Yang H, Shuid A, Sandai D, Chen X Front Genet. 2023; 14:1290036.

PMID: 38098472 PMC: 10720908. DOI: 10.3389/fgene.2023.1290036.

AP-1 Subunit JUNB Promotes Invasive Phenotypes in Endometriosis.

Wilson M, Reske J, Chandler R Reprod Sci. 2022; 29(11):3266-3277.

PMID: 35616875 PMC: 9669088. DOI: 10.1007/s43032-022-00974-3.

Determining the Molecular Background of Endometrial Receptivity in Adenomyosis.

Prasnikar E, Kunej T, Knez J, Repnik K, Potocnik U, Kovacic B Biomolecules. 2020; 10(9).

PMID: 32933042 PMC: 7563201. DOI: 10.3390/biom10091311.

Female Sexual Function in Women with Suspected Deep Infiltrating Endometriosis.

Lima R, Pereira A, Beraldo F, Gazzo C, Martins J, Lopes R Rev Bras Ginecol Obstet. 2018; 40(3):115-120.

PMID: 29609193 PMC: 10316930. DOI: 10.1055/s-0038-1639593.

References

Dotzlaw H, Leygue E, Watson P, Murphy L . Expression of estrogen receptor-beta in human breast tumors. J Clin Endocrinol Metab. 1997; 82(7):2371-4. DOI: 10.1210/jcem.82.7.4212. View

Luo X, Ding L, Chegini N . Gonadotropin-releasing hormone and TGF-beta activate MAP kinase and differentially regulate fibronectin expression in endometrial epithelial and stromal cells. Am J Physiol Endocrinol Metab. 2004; 287(5):E991-E1001. DOI: 10.1152/ajpendo.00200.2004. View

Lee Y, Tuckerman J, Nechushtan H, Schutz G, Razin E, Angel P . c-Fos as a regulator of degranulation and cytokine production in FcepsilonRI-activated mast cells. J Immunol. 2004; 173(4):2571-7. DOI: 10.4049/jimmunol.173.4.2571. View

Sampson J . Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. Am J Pathol. 2009; 3(2):93-110.43. PMC: 1931779. View

Crowe D, Brown T, Kim R, Smith S, Lee M . A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines. Mol Cell Biol Res Commun. 2000; 3(4):243-8. DOI: 10.1006/mcbr.2000.0221. View

Oliveira I, Lhullier C, Brum I, Spritzer P . Gene expression of type 2 17 beta hydroxysteroid dehydrogenase in scalp hairs of hirsute women. Steroids. 2003; 68(7-8):641-9. DOI: 10.1016/s0039-128x(03)00093-x. View

Yang W, Chen H, Au H, Chang C, Huang C, Yen Y . Serum and endometrial markers. Best Pract Res Clin Obstet Gynaecol. 2004; 18(2):305-18. DOI: 10.1016/j.bpobgyn.2004.03.003. View

McClelland R, Finlay P, Walker K, Nicholson D, Robertson J, Blamey R . Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer. Cancer Res. 1990; 50(12):3545-50. View

Matsuzaki S, Uehara S, Murakami T, Fujiwara J, Funato T, Okamura K . Quantitative analysis of estrogen receptor alpha and beta messenger ribonucleic acid levels in normal endometrium and ovarian endometriotic cysts using a real-time reverse transcription-polymerase chain reaction assay. Fertil Steril. 2000; 74(4):753-9. DOI: 10.1016/s0015-0282(00)00712-3. View

10.

Reis F, Maia A, Ribeiro M, Spritzer P . Progestin modulation of c-fos and prolactin gene expression in the human endometrium. Fertil Steril. 1999; 71(6):1125-32. DOI: 10.1016/s0015-0282(99)00138-7. View

11.

Giudice L, Kao L . Endometriosis. Lancet. 2004; 364(9447):1789-99. DOI: 10.1016/S0140-6736(04)17403-5. View

12.

Huang J, Shi Y, Zhou C . [Expressions of aromatase P450 and estrogen receptor in eutopic and ectopic endometrium in endometriosis and their correlation with endometriosis]. Zhonghua Fu Chan Ke Za Zhi. 2005; 40(3):171-4. View

13.

Noble L, Simpson E, Johns A, Bulun S . Aromatase expression in endometriosis. J Clin Endocrinol Metab. 1996; 81(1):174-9. DOI: 10.1210/jcem.81.1.8550748. View

14.

Pan H, Sheng J, Tang L, Zhu R, Zhou T, Huang H . Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients. Fertil Steril. 2007; 90(4):1000-7. DOI: 10.1016/j.fertnstert.2007.07.1386. View

15.

Fujishita A, Nakane P, Koji T, Masuzaki H, Chavez R, Yamabe T . Expression of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: an immunohistochemical and in situ hybridization study. Fertil Steril. 1997; 67(5):856-64. DOI: 10.1016/s0015-0282(97)81397-0. View

16.

Hennessy B, Harvey B, Healy V . 17beta-Estradiol rapidly stimulates c-fos expression via the MAPK pathway in T84 cells. Mol Cell Endocrinol. 2004; 229(1-2):39-47. DOI: 10.1016/j.mce.2004.10.001. View

17.

Asschert J, De Vries E, de Jong S, Withoff S, Vellenga E . Differential regulation of IL-6 promoter activity in a human ovarian-tumor cell line transfected with various p53 mutants: involvement of AP-1. Int J Cancer. 1999; 81(2):236-42. DOI: 10.1002/(sici)1097-0215(19990412)81:2<236::aid-ijc12>3.0.co;2-r. View

18.

. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997; 67(5):817-21. DOI: 10.1016/s0015-0282(97)81391-x. View

19.

Othman E, Salama S, Ismail N, Al-Hendy A . Toward gene therapy of endometriosis: adenovirus-mediated delivery of dominant negative estrogen receptor genes inhibits cell proliferation, reduces cytokine production, and induces apoptosis of endometriotic cells. Fertil Steril. 2007; 88(2):462-71. DOI: 10.1016/j.fertnstert.2006.11.046. View

20.

Matsuzaki S, Murakami T, Uehara S, Canis M, Sasano H, Okamura K . Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis. Fertil Steril. 2001; 75(6):1198-205. DOI: 10.1016/s0015-0282(01)01783-6. View